Catalyst Event
Moderna Inc (MRNA) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
6/1/2026, 12:00:00 AM
Moderna and Merck presented positive 5-year follow-up data for their personalized cancer vaccine (intismeran autogene/mRNA-4157) in combination with Keytruda for high-risk melanoma at the 2026 ASCO Annual Meeting on 2026-06-01. The 49% reduction in recurrence risk is estimated to cause a ≥10% price impact scheduled.
Korean Translation
2026년 6월 1일 ASCO 연례회의에서 암 백신(mRNA-4157)의 긍정적인 5년 추적 데이터를 발표함. 재발 위험 49% 감소라는 획기적 임상 결과로 인해 10% 이상의 주가 영향이 예상됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day in New York City to provide updates on strategy and long-term financial plans is scheduled. Impact estimated at >=1% as analyst days usually provide incremental updates; the event is scheduled.
9/16/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's Q2 FY2027 earnings release is scheduled.
8/20/2026, 12:00:00 AM
Lumentum Holdings Inc (LITE) · Earnings Release
Lumentum's next earnings release for Q4 2026 is scheduled for August 11, 2026; high importance as a primary volatility driver scheduled.
8/11/2026, 12:00:00 AM
Conocophillips (COP) · Earnings Release
As quarterly results typically drive price movements exceeding 10% for major energy producers, the Q2 2026 earnings release on 2026-08-06 is scheduled.
8/6/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Second Quarter 2026 financial results and conference call are scheduled for 2026-08-06 scheduled.
8/6/2026, 12:00:00 AM
Constellation Energy Corp (CEG) · Earnings Release
Q2 2026 earnings release on August 6, 2026, with low importance estimated based on historical price movements, is expected.
8/6/2026, 12:00:00 AM